Skip to content

Improving glycaemic control of patients with type 2 diabetes mellitus (T2DM) through management by a community based, multidisciplinary, integrated primary care / specialist level care service.

Is glycaemic control of patients with type 2 diabetes mellitus (T2DM) improved through management by a community based, multidisciplinary, integrated primary care / specialist level care service relative to comparable patients receiving usual care at a specialist outpatient diabetes clinic.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000010392
Acronym
ICDMS
Enrollment
250
Registered
2008-01-10
Start date
2007-09-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This research aims to improve quality of life in patients with type 2 diabetes by building the capacity of primary care and providing accessible, evidence based care in the community through multidisciplinary collaboration and integration across the primary and tertiary interface. The primary objective of this research is to investigate if glycaemic control of patients with type 2 diabetes can be improved through management at the Inala Chronic Disease Management Service (ICDMS) relative to comparable patients receiving usual care at the PAH endocrinology outpatients clinic. Other important objectives of the research include: * To improve modifiable cardiovascular risk factors and microvascular complications of diabetes * To increase the capacity and scope of primary care to manage patients with type 2 diabetes * To restructure the organisation of care in order to improve the effectiveness of patient care * To develop a sustainable model of care that is generalisable to other chronic diseases. * To investigate the relative costs of the new model of care * To assess the acceptability to GPs of the ICDMS caring for patients traditionally referred to the specialist outpatients clinic * To assess the acceptability to patients of the ICDMS rather than usual care at a specialist outpatients clinic. A key component of the ICDMS will be the staged devolution of diabetes services from tertiary care to primary care through increasing the capacity of primary care to meet the needs of patients who would otherwise use hospital outpatient clinic services. Initially, the tertiary level service providers (particularly the endocrinologist) will be heavily involved in training, support and service provision. Their involvement will gradually decrease to a virtual consultative function interspersed with limited patient contact. The proposed research is a structured and rational approach to evaluating the efficaciousness and effectiveness of the ICDMS. To achieve this, an open controlled trial of patient care at the ICDMS compared with usual care at the PAH diabetes outpatient clinic is proposed. Additionally, a nested cluster randomized controlled trial is proposed to test the effectiveness of the upskilling component of the project – general practices will be randomised to either receive the upskilling immediately or to be a wait-listed control group.

Interventions

There are 2 levels of the intervention: the patient level and the general practice level. Patient level intervention: The Inala Chronic Disease Management Service (ICDMS) provides multidisciplinary, coordinated and comprehensive care appropriate to the needs of the individual patient based on a systematic assessment of glycaemic control, presence of recognised complications of T2DM, and lifestyle and behavioural considerations. Patients will attend the ICDMS for management of acute complicatio

There are 2 levels of the intervention: the patient level and the general practice level. Patient level intervention: The Inala Chronic Disease Management Service (ICDMS) provides multidisciplinary, coordinated and comprehensive care appropriate to the needs of the individual patient based on a systematic assessment of glycaemic control, presence of recognised complications of T2DM, and lifestyle and behavioural considerations. Patients will attend the ICDMS for management of acute complications of T2DM. Once blood sugar levels and/or other complications have stabilised, the patient will be discharged back to their usual General Practitioner (GP). Patients will be followed up for 12 months for the ICDMS evaluation. General practice / primary care level – an education and training program for GPs and general practice nurses. The education and training program for GPs consists of a number of different, inter-related activities, and will continue for at least 12 months. Participation in any of the activities will enable the GPs to gain Professional Development points in the Royal Australian College of General Practitioners (RACGP) Quality Assurance and Continuing Professional Development (QA&CPD) program. One activity are the monthly, one hour Case Based Discussions. The program for these discussions is relatively informal, and is adapted according to the needs of the attending GPs, the patients seen at the ICDMS, and any "hot topics" in diabetes care. GPs can also participate in the more formal, eight week "clinical fellow" training. Each session is 1.5 hours. The clinical fellow training aims to provide GPs with advanced skills, knowledge and confidence in caring for patients with T2DM who have complex care needs eg. a number of co-morbidities. GPs will also be able to undertake supervised clinical attachments. These will consist of observing an endocrinologist over 10 hours of consultation time, and keeping a reflective diary of the experience. The practice nurse education and training program will consist of a series (approximately 3) of 2 hour seminars that are aimed at enabling the practice nurse take a more active role in providing comprehensive, coordinated care for patients with T2DM.

Sponsors

Community & Primary Health Services, Queensland Health
Lead SponsorGovernment body

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. patients with T2DM referred by GPs in the Inala catchment area for specialist management of their diabetes. 2. 18 yrs or older 3. willing to provide informed consent 4. have intact cognition

Exclusion criteria

1. patients on haemodialysis or renal transplant patients 2. patients with insufficient hypoglycaemic awareness 3. patients who are pregnant

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 31, 2026